2,253 reports of this reaction
2.2% of all ESTROGENS, CONJUGATED reports
#7 most reported adverse reaction
FATIGUE is the #7 most commonly reported adverse reaction for ESTROGENS, CONJUGATED, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 2,253 FDA adverse event reports linking ESTROGENS, CONJUGATED to FATIGUE. This represents approximately 2.2% of all 102,186 adverse event reports for this drug.
Patients taking ESTROGENS, CONJUGATED who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for ESTROGENS, CONJUGATED, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for ESTROGENS, CONJUGATED:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 2,253 FDA reports for ESTROGENS, CONJUGATED. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.2% of all adverse event reports for ESTROGENS, CONJUGATED, making it a notable side effect.
If you experience fatigue while taking ESTROGENS, CONJUGATED, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.